Recently, molecular alterations in ERBB4/HER4 receptor (loss-of-function) or in NRG1 have been linked to several neurological diseases such as amyotrophic lateral sclerosis (ALS) and schizophrenia [8, 9, 22]. This evidence concerns the gene ERBB4 and schizophrenia.